Monash University’s AI supercomputer MAVERIC is officially launched, with researchers already using its advanced c...
Australia-based Gelteq has announced the establishment of a new Gelteq Centre of Excellence in Guangdong Province, China...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
Medable Inc., the leading technology platform for agentic AI-powered clinical development, today announced its Agentic A...
China-based Everest Medicines has entered into an exclusive licensing and collaboration agreement with US-based Travere ...
Japan-based FunPep and Crafton Biotechnology have entered into a joint research agreement and commenced collaborative re...
The Ministry of Food and Drug Safety (MFDS) in South Korea has established the "Medical Product Approval and Review...
M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a gl...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...
Temasek Life Sciences Laboratory has highlighted the importance of life sciences research in strengthening Asia’s ...
China-based Haisco Pharmaceutical Group has announced a licensing and research collaboration with American firm Eli Lill...
Japan-based startup Toregem BioPharma has raised approximately $5.3 million (JPY 850 million) in Pre-Series C financing ...
Biond Biologics, a private clinical-stage biotechnology company developing first-in-class immunotherapies for cance...
The Victorian Heart Hospital and the Victorian Heart Institute will lead a first-in-human clinical trial of a new invest...
Samsung Epis Holdings Co., an investment holding company dedicated to innovation in biopharmaceuticals and biotechnology...
Taiwan-based startup TFBS Bioscience, Inc. and Australia's QIMR Berghofer Medical Research Institute have jointly announ...
Japan-based Asahi Kasei Life Science has acquired the license rights for a novel antibody-drug conjugate (ADC) technolog...
CapitaLand Group (CapitaLand) today officially opened Geneo, a life sciences and innovation hub at Singapore Sci...
Australia-s Monash University recently signed its second five-year agreement (2026-2030) with Suzhou Industrial Park (SI...
Accro Bioscience Inc., a China-based clinical-stage biotechnology startup pioneering the development of novel thera...
A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Si...
Shanghai Fosun Pharmaceutical (Group) and South Korea-based AriBio Co., a biopharmaceutical company focused on neurodege...
ImmunityBio, Inc., a commercial-stage immunotherapy company, has announced an exclusive US Development and Supply Agreem...
